Here is our Top Docs 2025 profile on Jeffrey Zonder, M.D., who is part of the Karmanos Cancer Institute’s Multiple Myeloma and Amyloidosis Multidisciplinary Team.

A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin greatly reduced transthyretin levels in patients with ...

Intellia Therapeutics, Inc. (NTLA) shares ended the last trading session 19.7% higher at $24.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

DelveInsight's Hereditary Transthyretin Amyloidosis Market Insights report includes a comprehensive understanding of current ...

However, its projections look too optimistic, and the stock carries considerable risk. 10 stocks we like better than Intellia ...

Watercolour prints of local doors, painted by late Frome stalwart John Birkett-Smith, are being exhibited and sold in his ...

About AL Amyloidosis AL amyloidosis is caused by abnormal plasma cells in the bone marrow, which produce misfolded amyloid proteins that build-up in the heart, kidney, and liver, causing heart and ...

Cardiologist Dmitry Yaranov highlights amyloidosis as an underdiagnosed cause of heart failure, often mistaken for hypertension or aging. This condition involves misfolded proteins stiffening the ...

University College London's National Amyloidosis Center leads a multinational team reporting that a single infusion of an in ...

(Alexandria, MN)--The 2025 Walk to End Alzheimer's disease is set for tomorrow (Saturday) in Alexandria. Registration will ...

Alnylam Pharmaceuticals ( NASDAQ: ALNY) has pulled a television ad for its drug Amvuttra (vutrisiran) after the U.S. FDA determined the spot was misleading. Amvuttra is approved for two heart ...

With several disease-modifying therapies available for transthyretin amyloid cardiomyopathy (ATTR-CM) -- and more waiting in ...